المؤلفون: Anderson P., Grills N., Thomas M., Wong C.C.

مصطلحات الفهرس: female, food allergy, human, hypertension/si [Side Effect], India, major clinical study, male, moon face/si [Side Effect], observational study, outpatient department, papule/si [Side Effect], perception, pharmacist, prescription, rosacea/si [Side Effect], rural area, scabies, side effect/si [Side Effect], skin disease, stria/si [Side Effect], tinea/si [Side Effect], amiton, beclometasone/pv [Special Situation for Pharmacovigilance], beclometasone/tp [Topical Drug Administration], beclometasone dipropionate, betamethasone/pv [Special Situation for Pharmacovigilance], betamethasone/tp [Topical Drug Administration], betamethasone valerate, chlorocresol, fluocinolone/pv [Special Situation for Pharmacovigilance], fluocinolone/tp [Topical Drug Administration], fluocinonide, gentamicin, ketoconazole, miconazole, mometasone furoate/pv [Special Situation for Pharmacovigilance], mometasone furoate/tp [Topical Drug Administration], neomycin, ofloxacin, ornidazole, salicylic acid, steroid/ae [Adverse Drug Reaction], steroid/po [Oral Drug Administration], steroid/pe [Pharmacoeconomics], steroid/pv [Special Situation for Pharmacovigilance], steroid/tp [Topical Drug Administration], terbinafine, tolnaftate, adoderm mn, aluderm, amitone 5, betamil, betnovate n, bifine plus, candid 3d, candid b, canditas bg, castor nf, cbn, ceflox cf, cipro cf, clobenate gm, clobeta gm, clobezine cm, clobriv mg, clorap s, clostar gm, clotebate gm, cosvate gm, dermacin k 5, dermek tc, dermiford, dermiford k 5, dermifrench kt, dermikem oc, dermikemoc, evzole, flucort h, fourderm, iobate, laboderm oc, lobate gm, lozivate, lozivate mf, lucobet gm, lupiderm gm, medisalic, neo clobenate gm, neoclobenate gm, nikderm plus, nuforce gm, oltef nf, onabet b, onflox tc, orkaderm, orkid 4, orniderm, panderm plus, pardum plus, quadriderm, quadriderm rf, ring out plus, sarvocin ct, sertamide b, soltex, sure kt, surfaz sn, tecderm kt, terbicad, terbinaforce plus, terderm plus, terogood, tocoderm plus, totalderm plus, unikderm, zenoderm, zincodem gm, zole f, turgoderm oc, ciprofloxacin, clioquinol, clobetasol propionate/pv [Special Situation for Pharmacovigilance], clobetasol propionate/tp [Topical Drug Administration], clobetasone/pv [Special Situation for Pharmacovigilance], clobetasone/tp [Topical Drug Administration], clotrimazole, flumetasone acetate, acne/si [Side Effect], adolescent, adult, article, behavior, dermatology, diabetes mellitus/si [Side Effect], drug cost, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29235
BMJ Open
Click here for full text options
LibKey Link

المؤلفون: Anderson P., Grills N., Thomas M., Wong C.C.

مصطلحات الفهرس: female, food allergy, human, hypertension/si [Side Effect], India, major clinical study, male, moon face/si [Side Effect], observational study, outpatient department, papule/si [Side Effect], perception, pharmacist, prescription, rosacea/si [Side Effect], rural area, scabies, side effect/si [Side Effect], skin disease, stria/si [Side Effect], tinea/si [Side Effect], amiton, beclometasone/pv [Special Situation for Pharmacovigilance], beclometasone/tp [Topical Drug Administration], beclometasone dipropionate, betamethasone/pv [Special Situation for Pharmacovigilance], betamethasone/tp [Topical Drug Administration], betamethasone valerate, chlorocresol, fluocinolone/pv [Special Situation for Pharmacovigilance], fluocinolone/tp [Topical Drug Administration], fluocinonide, gentamicin, ketoconazole, miconazole, mometasone furoate/pv [Special Situation for Pharmacovigilance], mometasone furoate/tp [Topical Drug Administration], neomycin, ofloxacin, ornidazole, salicylic acid, steroid/ae [Adverse Drug Reaction], steroid/po [Oral Drug Administration], steroid/pe [Pharmacoeconomics], steroid/pv [Special Situation for Pharmacovigilance], steroid/tp [Topical Drug Administration], terbinafine, tolnaftate, adoderm mn, aluderm, amitone 5, betamil, betnovate n, bifine plus, candid 3d, candid b, canditas bg, castor nf, cbn, ceflox cf, cipro cf, clobenate gm, clobeta gm, clobezine cm, clobriv mg, clorap s, clostar gm, clotebate gm, cosvate gm, dermacin k 5, dermek tc, dermiford, dermiford k 5, dermifrench kt, dermikem oc, dermikemoc, evzole, flucort h, fourderm, iobate, laboderm oc, lobate gm, lozivate, lozivate mf, lucobet gm, lupiderm gm, medisalic, neo clobenate gm, neoclobenate gm, nikderm plus, nuforce gm, oltef nf, onabet b, onflox tc, orkaderm, orkid 4, orniderm, panderm plus, pardum plus, quadriderm, quadriderm rf, ring out plus, sarvocin ct, sertamide b, soltex, sure kt, surfaz sn, tecderm kt, terbicad, terbinaforce plus, terderm plus, terogood, tocoderm plus, totalderm plus, unikderm, zenoderm, zincodem gm, zole f, turgoderm oc, ciprofloxacin, clioquinol, clobetasol propionate/pv [Special Situation for Pharmacovigilance], clobetasol propionate/tp [Topical Drug Administration], clobetasone/pv [Special Situation for Pharmacovigilance], clobetasone/tp [Topical Drug Administration], clotrimazole, flumetasone acetate, acne/si [Side Effect], adolescent, adult, article, behavior, dermatology, diabetes mellitus/si [Side Effect], drug cost, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/29235
BMJ Open
LibKey Link